Cite
HARVARD Citation
Rosen, L. et al. (n.d.). 30LBA A Phase 1 dose escalation, safety, and pharmacokinetic study of PF-06650808, an anti-Notch3 antibody drug conjugate, in adult patients with advanced solid tumors. European journal of cancer. pp. S725-. [Online].